Fever Power
Business Today India|April 16, 2023
The market for anti-flu drug Oseltamivir in India has grown over 3x in the past three years, with Cipla, Hetero and Macleods being the biggest gainers
NEETU CHANDRA SHARMA
Fever Power

IT’S THAT TIME of the year again when the spread of influenza reaches fever pitch. And with the flu season on us, can medication to treat it be far behind? Data from Pharmarack, an integrated B2B healthcare platform, reveals that sales of antiviral drug Oseltamivir, commonly known as Tamiflu, has seen healthy growth in the past three months. In December 2022, at least 227,000 units of the drug were sold, which shot up to 294,000 units in January 2023 and 395,000 units in February 2023, with a value of ₹9.7 crore, ₹12.8 crore and ₹29 crore, respectively.

The uptick in sales can be linked to the rising flu cases in the country. According to the data available on the Integrated Disease Surveillance Programme-Integrated Health Information Platform (IDSP-IHIP) under the Ministry of Health and Family Welfare, a total of 3,038 laboratory-confirmed cases of various subtypes of influenza, including H1N1 and H3N2, had been reported till March 9, 2023, by the states.

This story is from the April 16, 2023 edition of Business Today India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the April 16, 2023 edition of Business Today India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS TODAY INDIAView All
"Inaction is worse than mistakes"
Business Today India

"Inaction is worse than mistakes"

What was the problem you were grappling with?

time-read
1 min  |
January 05, 2025
TEEING OFF WITH TITANS
Business Today India

TEEING OFF WITH TITANS

BUSINESS TODAY GOLF RESUMES ITS STORIED JOURNEY WITH THE 2024-25 SEASON OPENER IN DELHI-NCR. THERE ARE SIX MORE CITIES TO COME

time-read
2 mins  |
January 05, 2025
AI FOOT FORWARD
Business Today India

AI FOOT FORWARD

THE WHO'S WHO OF THE AI WORLD GATHERED AT THE TAJ MAHAL PALACE IN MUMBAI TO DELIBERATE THE TRANSFORMATIVE IMPACT OF AI ON INNOVATION, INDUSTRIES, AND EVERYDAY LIFE.

time-read
1 min  |
January 05, 2025
Decolonising the Walls
Business Today India

Decolonising the Walls

ART START-UP MAAZI MERCHANT IS ON A MISSION TO BRING INDIA'S FORGOTTEN ART BACK HOME

time-read
6 mins  |
January 05, 2025
"I'm bringing Kotak under one narrative, one strategy, one umbrella”
Business Today India

"I'm bringing Kotak under one narrative, one strategy, one umbrella”

Ashok Vaswani is a global banker who spent most of his career overseas at institutions like Citi Group and Barclays, among others.

time-read
9 mins  |
January 05, 2025
CHOOSING THE CHAMPIONS
Business Today India

CHOOSING THE CHAMPIONS

The insights and methodology behind the BT-KPMG India's Best Banks and NBFCs Survey 2023-24.

time-read
8 mins  |
January 05, 2025
'INDIA IS AT AN EXTREMELY SWEET SPOT'
Business Today India

'INDIA IS AT AN EXTREMELY SWEET SPOT'

The jury members of the BT-KPMG Survey of India's Best Banks and NBFCs discuss developments in the banking sector and more

time-read
6 mins  |
January 05, 2025
FROM CRISIS TO TRIUMPH
Business Today India

FROM CRISIS TO TRIUMPH

Dinesh Kumar Khara stewarded SBI through multiple challenges during his tenure, while ensuring that profits tripled, productivity soared, and the bank consolidated its global standing

time-read
3 mins  |
January 05, 2025
AT A CROSSROADS
Business Today India

AT A CROSSROADS

BANKS ARE FACING CHALLENGES ON BOTH SIDES OF THE BALANCE SHEET-ASSETS AS WELL AS LIABILITIES-WHICH ARE PUTTING PRESSURE ON MARGINS.

time-read
5 mins  |
January 05, 2025
EXPANSIVE VISION
Business Today India

EXPANSIVE VISION

Bajaj Finance, an outlier in terms of digitisation, faces stiff competition. But it continues to expand its reach

time-read
4 mins  |
January 05, 2025